S Parrish Winesett

S Parrish Winesett, M.D.

Clinical Associate Professor

Department: MD-PEDS-NEUROLOGY
Business Phone: (352) 273-8920
Business Email: parrish.winesett@ufl.edu

On This Page

About S Parrish Winesett

Hello, my name is Steven Parrish Winesett, MD, and I am a board-certified pediatric neurologist and pediatric epileptologist. I have extensive experience with complex epilepsy, including pre-surgical evaluations and advanced EED monitoring. I also have expertise in nonpharmagologic treatments for epilepsy, including vagal nerve stimulation and special diets, such as the ketogenic diet and the modified Atkins diet.

I graduated from the University of Florida with a degree in microbiology and received my medical degree from the University of South Florida. I trained in pediatrics and internal medicine at the University of South Florida, child neurology at Vanderbilt University and epilepsy at the University of South Florida.

Teaching Profile

Courses Taught

  1. MDC7400 – Pediatric Clerkship

    College of Medicine

  2. PAS5020 – Intro to Medicine 2

    College of Medicine

Board Certifications

  • Epilepsy
    American Board of Psychiatry and Neurology
  • Neurology with Special Qualification in Child Neurology
    American Board of Psychiatry and Neurology

Clinical Profile

Subspecialties

  • Pediatric Neurology

Areas of Interest

  • Adrenoleukodystrophy
  • Epilepsy
  • Epilepsy in Children
  • Magnetoencephalography (MEG)
  • Metachromatic Leukodystrophy
  • Tuberous Sclerosis

Publications

Academic Articles

Grants

  1. A Phase 3 Randomized, Placebo-controlled, Double-blind Study to Evaluate the Efficacy and Safety of BBP-418 (ribitol) in Patients with Limb Girdle Muscular Dystrophy 2I (LGMD2I)

    Active

    Role:
    Principal Investigator
    Funding:
    FORTREA via ML BIO SOLUTIONS
  2. CTOA

    Active

    Role:
    Principal Investigator
    Funding:
    UNIV OF FLORIDA
  3. Compassionate Use Program for olipudase alfa enzyme replacement therapy for patients with chronic acid sphingomyelinase deficiency (ASMD)

    Role:
    Principal Investigator
    Funding:
    SANOFI US SERVICES
  4. Phase 1b, Multi-center, Randomized, Double-Blind, Placebo-Controlled, Rising Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of VK0214, in Subjects with the Adrenomyeloneuropathy Form (AMN) of X-linked Adrenoleukodystrophy (X-ALD)

    Role:
    Principal Investigator
    Funding:
    INCLIN INC via VIKING THERAPEUTICS
  5. Open Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Pegunigalsidase Alfa (PRX-102) in Patients with Fabry Disease

    Role:
    Principal Investigator
    Funding:
    CHIESI FARMACEUTICI
  6. Effects of Cannabidol Use on the Developing Brain in Medically Refractory Childhood Epilepsy

    Role:
    Principal Investigator
    Funding:
    FL DEPT OF HLTH REFRACTORY INTRACTABLE E

Education

  1. Fellowship, Epilepsy

    University of South Florida

  2. Master of Business Administration

    University of South Florida

  3. Residency, Neurology with special competence in Pediatrics

    Vanderbilt

  4. Combined Internal Medicine/ Pediatrics Residency

    University of South Florida

  5. Medical Degree

    University of South Florida

Contact Details

Phones:
Business:
(352) 273-8920
Emails:
Administrative Specialist II:
Addresses:
Business Mailing:
PO Box 100296
GAINESVILLE FL 32610
Business Street:
ARB RG-140
1600 SW Archer Road
Gainesville FL 32610